Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
Clinical trial NCT00281957 · COMPLETED
Trial details
- NCT number
- NCT00281957
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.